Titenare Gxl Technologies Private Limited

Become the proven, trusted and value-added one stop solution provider to the Pharmaceutical, Food, Healthcare, Personal Care, Device and Electronic Industries.

BE Studies/CRO Management Services

  • Identification and selection of CROs aligned with Client criteria and nature of studies
  • Technical and commercial due diligences of the selected CRO/CDO sites
  • Negotiations on scope of work, commercial and technical agreements
  • Preparation of entire management and quality systems for the management of CROs
  • Audit of CRO sites as per target regulatory standards for USFDA, EUGMP, ROW
  • Comprehensive monitoring of studies at multiple CRO/CDO sites
  • Assistance in preparation of study guidelines and protocols creation. Medical device risk assessment
  • Intermediate assessment of data and progress during studies
  • Assistance in review and finalization of study reports consistent with ANDA/CE Mark/IEC6060-1
  • Specific project based
  • Rent-a-resource: Monthly retainer based
  • Resource placement at the manufacturing sites

Business solutions and services

Access to right Products & Funding


  • Strategy and branding
  • New Product Strategies – R&D, In licensing, out licensing
  • Global product development
  • Mergers & Acquisitions
  • Advisory services
  • Turnkey project solutions
  • Fund raising support

Access to integrated Services


  • Project Management
  • Facilities Design & Engineering
  • Regulatory Affairs – Drug & Device
  • Quality Management Systems
  • Development Services – Product/Analytical
  • API Development Monitoring Support
  • Technology/Site Transfers
  • Third Party Audit and Compliance
  • ISO//CE Mark/UL certifications
  • Global Supply Chain Management
  • Intellectual Property

Access to right Markets


  • Market Assessment
  • Competitor Differentiation
  • Strategy and branding
  • Pipeline Prioritization
  • Competitor and customer perspectives
  • Complete organization value maps.
  • Implementation planning and support
  • Market access: India, EU, US, RoW